Workflow
脑机接口现新进展,6只概念股年内涨超80%
Zheng Quan Shi Bao Wang·2025-08-25 08:10

Core Viewpoint - The launch of the world's first multi-center clinical trial for brain-computer interface (BCI) aimed at precise diagnosis and treatment of hydrocephalus marks a significant advancement in the field, highlighting China's growing innovation in BCI technology and its integration with the medical industry [1] Industry Summary - The BCI market in China is projected to grow from 3.2 billion yuan in 2024 to 6.14 billion yuan by 2028, indicating a robust expansion in this sector [1] - The BCI sector is recognized as one of the hottest investment areas, attracting significant capital interest [1] Company Summary - BCI concept stocks have seen an average increase of 47.88% year-to-date, significantly outperforming the Shanghai Composite Index [1] - Six companies have reported cumulative increases exceeding 80%, including Innovation Medical, Hanwei Technology, Xiangyu Medical, Aipeng Medical, Lepu Medical, and Botao Biological [1]